Skip to main content

Table 3 Results of the main regression analyses

From: One-year follow-up healthcare costs of patients diagnosed with skin cancer in Germany: a claims data analysis

Parameter Estimate Standard error 95% CI Z Pr >|Z|
MM, main analysis
 Intercept 7.5284 0.0336 7.4626 7.5942 224.16  < .0001
 Scr -0.3563 0.0317 -0.4185 -0.2942 -11.24  < .0001
 Per 0.8360 0.0317 0.7739 0.8981 26.39  < .0001
 Scr*Per -0.1720a 0.0466 -0.2634a -0.0807a -3.69 0.0002
 EH 0.1036 0.0061 0.0916 0.1155 17.01  < .0001
 PBM 0.1391 0.0082 0.1231 0.1551 17.04  < .0001
NMSC, main analysis
 Intercept 7.3222 0.0142 7.2943 7.3501 514.17  < .0001
 Scr -0.2106 0.0132 -0.2364 -0.1847 -15.95  < .0001
 Per 0.3476 0.0085 0.3310 0.3643 40.95  < .0001
 Scr*Per 0.0249a 0.0130 -0.0006a 0.0504a 1.92 0.0555
 EH 0.1013 0.0027 0.0960 0.1065 37.95  < .0001
 PBM 0.1640 0.0031 0.1579 0.1701 52.64  < .0001
  1. CI Confidence interval, Scr dummy-variable to distinguish between routine SCS that has taken place and no routine SCS, Per dummy-variable to distinguish between pre- and post-observation period, PBM Pharmacy-based Metric, EH Elixhauser Comorbidity Index; Screening*Period denotes the DiD estimator
  2. aDifferences in coefficients between table and text arise as the text reports exact numbers, calculated as ((e^coefficient)-1)*100%